Total Funding
31
Total FundingPost-IPO Equity raised
Growth Score
pts
Heat Score
-17 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
220896
Intec Pharma is a drug development company that applies gastric retention technology to develop improved formulations of existing drugs.
Acquired by 
Indaptus Therapeutics
John Kozarich: Chairman of the BoardPast Role: ActivX Biosciences, Chairman and President
Zeev Weiss: EVP
Indaptus Therapeutics
About the Company
Intec Pharma is a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology. The Company's Accordion Pill is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs in development by utilizing an efficient gastric
retention and specific release mechanism.
